Procter & Gamble Vs Unilever: Who Holds the Power in the FMCG Race? — Positive

PG  UL   Zacks Investment Research — May 28, 2025

PG and UL stand tall in the FMCG arena, with PG showcasing brand strength and pricing power, while UL leverages global reach and innovation to fuel momentum.

image for news Procter & Gamble Vs Unilever: Who Holds the Power in the FMCG Race?

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Napco Security Technologies, Inc. ("Napco" or "the Company") (NASDAQ: NSSC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2024, and February 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 24, 2025.

image for news NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Krispy Kreme To Contact Him Directly To Discuss Their Options

image for news DNUT Investors Have the Opportunity to Lead the Krispy Kreme Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=150567&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

image for news Securities Fraud Class Action Filed Against Viatris Inc. (VTRS) - Levi & Korsinsky Reminds Investors of June 3, 2025

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150566&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Organon & Co. (OGN) Investors - Lead Plaintiff Deadline on July 22, 2025

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Everus Construction Group, Inc. (NYSE:ECG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/everus-construction-group-inc-lawsuit-submission-form?prid=150568&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.

image for news Join Class Action to Recover Losses from Everus Construction Group, Inc. (ECG) - Contact Levi & Korsinsky Before June 3, 2025

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ: CAR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 16, 2024 and February 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 24, 2025.

image for news CAR Investors Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ: IOVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 9, 2024 and May 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 14, 2025.

image for news IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Macy's, Inc. (M) Q1 2025 Earnings Call Transcript — Neutral

M   Seeking Alpha — May 28, 2025

Macy's, Inc. (NYSE:M ) Q1 2025 Earnings Conference Call May 28, 2025 8:00 AM ET Company Participants Pamela Quintiliano - VP of IR Tony Spring - Chairman and CEO Adrian Mitchell - COO and CFO Conference Call Participants Blake Anderson - Jefferies Paul Kearney - Barclays Brooke Roach - Goldman Sachs Alex Straton - Morgan Stanley Matthew Boss - JPMorgan Dana Telsey - Telsey Advisory Group Michael Binetti - Evercore ISI Chuck Grom - Gordon Haskett Operator Greetings, and welcome to the Macy's, Inc. First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.

image for news Macy's, Inc. (M) Q1 2025 Earnings Call Transcript

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NET Power Inc. ("Net Power" or "the Company") (NYSE: NPWR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 9, 2023 and March 7, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 17, 2025.

image for news NPWR Investors Have Opportunity to Lead NET Power Inc. Securities Fraud Lawsuit with the Schall Law Firm

SEATTLE--(BUSINESS WIRE)--Porch Group Announces Closing of Transaction Retiring Majority of 2026 Unsecured Notes.

image for news Porch Group Announces Closing of Transaction Retiring Majority of 2026 Unsecured Notes and Plans to Retire Additional Debt With Limited Anticipated Dilution to Stockholders

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=150565&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.

image for news Investor Alert: Deadline Approaching to Join Ibotta, Inc. (IBTA) Class Action - Contact Levi & Korsinsky

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bakkt To Contact Him Directly To Discuss Their Options

image for news BKKT Investors Have the Opportunity to Lead the Bakkt Holdings Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

image for news ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR

Pagaya Vs. Upstart: Why Pagaya's Strategy Offers A Safer Bet — Negative

PGY  UPST   Seeking Alpha — May 28, 2025

The company leverages advanced AI to assess creditworthiness, similar to Upstart. Current macro uncertainty and declining consumer sentiment could threaten Pagaya's loan performance, funding costs, and overall business outlook. Recent earnings show a few credit-related losses and portfolio write-downs, highlighting the company's exposure to credit risk.

image for news Pagaya Vs. Upstart: Why Pagaya's Strategy Offers A Safer Bet

SunOpta Inc. to Participate in Upcoming Investor Conference — Neutral

STKL   Business Wire — May 28, 2025

MINNEAPOLIS--(BUSINESS WIRE)--SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), the company that delivers customized supply chain solutions and innovation for top brands, retailers and foodservice providers across a broad portfolio of beverages, broths and better-for-you snacks, today announced that the Company will participate in the TD Cowen Future of the Consumer Conference, to be held June 3-4, 2025 in New York, N.Y. The Company will meet with investors and participate in a.

image for news SunOpta Inc. to Participate in Upcoming Investor Conference

UUUU Vs LEU: Which US Uranium Stock is the Better Buy Right Now? — Positive

LEU  UUUU   Zacks Investment Research — May 28, 2025

Centrus Energy hits 52-week high as U.S. nuclear push boosts demand. Energy Fuels ramps up uranium output but provides lower 2025 sales and earnings estimates.

image for news UUUU Vs LEU: Which US Uranium Stock is the Better Buy Right Now?

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Everus To Contact Him Directly To Discuss Their Options

image for news ECG Investors Have the Opportunity to Lead the Everus Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Capri Holdings Limited (CPRI) Q4 2025 Earnings Call Transcript — Neutral

CPRI   Seeking Alpha — May 28, 2025

Capri Holdings Limited (NYSE:CPRI ) Q4 2025 Earnings Conference Call May 28, 2025 8:30 AM ET Company Participants Jennifer Davis - VP, IR John D. Idol - Chairman and CEO Thomas J.

image for news Capri Holdings Limited (CPRI) Q4 2025 Earnings Call Transcript

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zenas BioPharma, Inc. ("Zenas" or "the Company") (NASDAQ: ZBIO) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025.

image for news ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm